202201020328/Guangzhou Science and Technology Project[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Chemotherapy-elicited extracellular vesicle CXCL1 from dying cells promotes triple-negative breast cancer metastasis by activating TAM/PD-L1 signaling.

Wang S, Li J, Hong S, Wang N, Xu S, Yang B, Zheng Y, Zhang J, Pan B, Hu Y, Wang Z. Wang S, et al. J Exp Clin Cancer Res. 2024 Apr 23;43(1):121. doi: 10.1186/s13046-024-03050-7. J Exp Clin Cancer Res. 2024. PMID: 38654356 Free PMC article.

Developing liver-targeted naringenin nanoparticles for breast cancer endocrine therapy by promoting estrogen metabolism.

Zhao Y, Tan H, Zhang J, Zhan D, Yang B, Hong S, Pan B, Wang N, Chen T, Shi Y, Wang Z. Zhao Y, et al. J Nanobiotechnology. 2024 Mar 19;22(1):122. doi: 10.1186/s12951-024-02356-0. J Nanobiotechnology. 2024. PMID: 38504208 Free PMC article.

Baohuoside I chemosensitises breast cancer to paclitaxel by suppressing extracellular vesicle/CXCL1 signal released from apoptotic cells.

Wang S, Li J, Xu S, Wang N, Pan B, Yang B, Zheng Y, Zhang J, Peng F, Peng C, Wang Z. Wang S, et al. J Extracell Vesicles. 2024 Jul;13(7):e12493. doi: 10.1002/jev2.12493. J Extracell Vesicles. 2024. PMID: 39051750 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Search Page

Filters